Welcome to our 7investing March Madness competition! Throughout this campaign, we’re matching popular stocks up against one another to determine which will be the best investment over the next three years. And then, by voting in the poll at the bottom of the article, you can help us determine which stock will go on to the next round!

Our rankings are determined by the total return of the stock during calendar 2022. The highest-ranked stock had the best overall return of those in our tournament, and our lowest-ranked stock had the lowest overall return.

In this first-round matchup, mRNA and COVID-vaccine developer Moderna (NASDAQ: MRNA) is up against the electric vehicle innovator Tesla (NASDAQ: TSLA). Moderna’s stock fell just (30%) during 2022, while Tesla tumbled (69%).

But past performance is not predictive of future returns. Which of these stocks do you believe will provide investors with the best forward three-year return? Read our investing thesis and cast your vote in the poll below!

Follow our entire Market Madness tournament at 7investing.com/marketmadness 

Our Market Madness tournament is in support of our new 7investing Starter membership, which we are giving away free during the entire month of March. To get started with Starter — and to see how it’s already beating the market significantly — click here to automatically apply your “madness” promo code.